Three Other Companies, Including RGnomics, Also Pass Preliminary Listing Review
The Pinkfong Company, which owns the intellectual property (IP) rights to "Baby Shark," has passed the first hurdle for its initial public offering (IPO).
On September 19, the KOSDAQ Market Division of the Korea Exchange announced that it had approved preliminary listing reviews for four companies, including The Pinkfong Company.
The Pinkfong Company is engaged in the production and distribution of films, videos, and broadcast programs. Last year, its consolidated sales reached 97.4 billion won, with an operating profit of 18.8 billion won. Mirae Asset Securities and Samsung Securities are acting as underwriters. In addition to "Baby Shark," the company holds a variety of other IPs, such as "Pinkfong" and "Bebefinn."
RGnomics is a company specializing in the development of therapeutics and diagnostics for human diseases, as well as recombinant gene pharmaceuticals for diagnostics. Last year, it recorded an operating loss of 12.9 billion won. NH Investment & Securities and Samsung Securities are the underwriters.
Aimed Bio is a research and development company in natural sciences and engineering. Last year, its consolidated sales amounted to 11.8 billion won, with an operating loss of 400 million won. Mirae Asset Securities is the underwriter.
Nara Space Technology manufactures aircraft, spacecraft, and related components. Last year, it posted sales of 4.3 billion won and an operating loss of 4.4 billion won. Samsung Securities is the underwriter.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
